Forty crossbred barrows (average initial weight, 66.4 kg) were utilized to determine the effects of ractopamine (a phenethanolamine/beta adrenergic agonist) on protein accretion and synthesis, activities of cathepsins B, H, L and calcium-dependent proteinase and nucleic acid content of semitendinosus muscle (ST). All pigs were offered a 16% protein, mineral and vitamin fortified corn-soybean meal diet supplemented with either 0 or 20 ppm ractopamine for 14, 21, 28, 35 or 42 d. Protein synthesis (fractional rates) was studied in pigs at d 21 and 35; ST protease activities, protein and nucleic acid content were measured on d 14, 28 and 42. Ractopamine increased (P < .01) ST total protein content and maintained RNA muscle concentration and total ST muscle RNA content. DNA content (mg/g ST) declined (P < .05) upon ractopamine feeding, but total DNA per muscle remained unchanged except for d 42, when the ST muscles were largest. Fractional accretion rates (FAR) were 1.0 and 1.2% for control and ractopamine-fed pigs, respectively. Fractional protein synthesis rate (FSR) was higher (P < .06) in ractopaminefed pigs (6.1%/d) than in control pigs (4.4%/d). Fractional protein synthesis rate could account for the observed muscle hypertrophy and increased FAR. Estimated fractional breakdown rates (FBR = FSR -FAR) were 3.4%/d and 4.9%/d for control and ractopamine-fed pigs, respectively. The activities of the catheptic proteases and calciumdependent proteinase were not affected by the treatments.
Introduction
Adrenergic compounds (neurotransmitters [epinephrine and norepinephrine] August 25, 1988 . Accepted February 20, 1989 tion in pigs (Cunningham et al., 1963) . Isoproterenol administration resulted in hypertrophy of rat heart and tibialis muscle, but this hypertrophy was not mediated via testosterone or insulin (Deshaies et al., 1981) . In preliminary reports, ractopamine, a phenethanolamine/ BAh,, was shown to promote muscle hypertrophy when fed to finishing pigs at 20 ppm (Anderson et al., 1987a,b) . European workers showed that the administration of the BAA clenbuterol to rats resulted in skeletal muscle hypertrophy; this increased muscle protein deposition was due either to increased protein synthesis (Emery et al., 1984) or to decreased protein degradation . Eadara et al. (1988) showed that feeding rats cimaterol for 7 d depressed protein breakdown 2255 apremix provided per kg of diet: Vitamin A, 3,300 IU; vitamin I> 3, 600 IU; riboflavin, 3.3 mg; nicotinic acid, 17.6 mg; d-pantothenic acid, 13.2 rag; choline, 110 rag; vitamin B12, 19.8 Ixg; Zn, 74.8 mg; Fe, 9 .4 mg;, Mn, 37.4 rag; Cu, 9.9 rag; I, .5 rag; Se, .1 rag.
and increased protein synthesis; after 7 d these effects were no longer evident. Earlier work showed that isoproterenol appeared to depress protein turnover in acute rat hind limb perfusions (Li and Jefferson, 1977) , and Garber et al. (1976) demonstrated that catecholamines depressed amino acid release from rat skeletal muscle incubated in vitro.
The present study was designed to extend previous work on the effect of ractopamine on semitendinosus muscle (ST) growth in pigs. The primary goal of this research was to clarify the mechanism(s) whereby ractopamine enhanced muscle growth in pigs. This was accomplished by determining growth, protein accretion and protein synthesis and degradation rates of ST muscles in finishing pigs.
Materials and Methods
Animals and Treatments. Forty crossbred barrows (66.4 kg; 120 to 125 d of age) were obtained from and housed at the Swine Research Facility of Michigan State University. These pigs were assigned to a feeding trial and allotted into either the control or ractopamine group. Pigs were fed a 16% crude protein corn-soybean meal diet (Table 1) supplemented with either 0 or 20 ppm ractopamine (1-(4-hydroxyphenyl)-2-(1 methyl-3 (4 hydroxyphenyl) propylamino) ethanol) 7. Pigs were utilized for various experimental protocols as (Bergen et ai., 1987) . Fractional accretion rates (FAR, Waterlow et al., 1978) over the time interval from d 14 to 42 were estimated from ST muscle protein analysis.
Determination of Fractional Protein Synthesis Rate: Continuous Infusion of [14C]-
Tyrosine. The overall procedure followed to measure FSR were described earlier (Mulvaney et al., 1985; Bergen et al., 1987) . In this study, 2 to 3 d before isotope infusion, catheters were surgically inserted into pigs. For catheterization, pigs were premedicated with Azaparone 8 and Ketamine-HCl 9 and anesthetized with sodium pentobarbitol (10 mg/kg BW), followed by placement of the catheter into the right jugular vein. Catheters were kept patent with heparinized sterile saline. On infusion days, another catheter was inserted into an ear vein of each pig through which the isotol~, was infused with a Harvard infusion pump 10 (syringe 20 ml). Jugular blood sampies (10 ml) were obtained to determine specific activity of tyrosine during the infusion period (Bergen et al., 1987) . Each pig was infused with L-[U14C]tyrosine 11 (>450 Ci/ mol) dissolved in sterile .9% NaCI at a rate of 4.4 ~tCi/kg over a 6-h period. Immediately after the 6-h infusion, 10 ml of sodium pentobarbitol (50% w/v) was administered i.v. Samples of ST muscle were excised within 30 to 40 s and quickly frozen in liquid nitrogen and stored at --80"C.
Analytical Procedures. All ST samples were powdered with solid CO2 at -70*C. Semitendinosus muscle samples, obtained on d 14, 28 and 42, were analyzed for protein (AOAC, 1980) . Powdered ST muscle samples from the isotope infusion groups were treated with trichloracetic acid (TCA) and centrifuged at 10,000 x g for 30 min to precipitate the protein. Tyrosine specific activity was determined in the TCA-soluble as well as in 6 N (Waalkes and Undenfriend, 1957; Garlick and Marshall, 1972) as described by Bergen et al. (1987) . Briefly, tyrosine from the TCA-soluble pool was specifically isolated by enzymatic conversion of L-tyrosine to tyramine with L-tyrosine decarboxylase (E.C. 4.1.1.25). Selective extraction of tyramine followed by fluorometric analysis and radioactivity was determined by counting in a liquid scintillation spectrometer.
To determine tyrosine specific activity in TCA-preeipitated protein hydrolysates, hydrolysates were passed over a strong cation exchange column 12, washed with water and eluted with ammonium hydroxide. The amino acid fraction was flash-evaporated, resuspended in .01 N HCI and assayed for tyrosine by ion exchange chromatography (Bergen et al., 1987) . Another aliquot of the amino acid fraction (in .01 N HCI) was counted for radioactivity and the proportion of tyrosine of the total radioactivity in the amino acid fraction was determined by one-way thin-layer chromatography (Bergen et al., 1987) . Nucleic acids (DNA and RNA) were assayed in powdered muscle samples according to Munro and Fleck (1969) as modified in our laboratory (Bates et al., 1985) . divided by 2.
Fractional accretion rate was calculated as follows: FAR = Daily accretion rate/ST muscle pool size.
FSR was calculated using the equation described by Garlick et al. (1974) :
where SB and Si are the specific radioacuvities of the free and protein bound tyrosine in ST at the end of the infusion period; K S = FSR; R is the ratio of total tyrosine in muscle protein to tyrosine in the muscle free pool (we used 400, Mulvaney et al., 1985) and t is time in days; FSR values were solved by computer (Bergen et al., 1987) . Fractional breakdown rates (FBR) were calculated as the differences between FSR and FAR (FBR equals FSR minus FAR) as described by Millward et al. (1975) . Calcium-Dependent Proteinase and Cathepsin Assays. Calcium-dependent proteinases (CDP) were assayed according to Koohmariae et al. (1984) . Frozen muscle samples were homogenized in 2.5 volumes of .17 M Tris-HC1 buffer (pH 7.9) containing 4 mM EDTA. The homogenate was centrifuged at 14,000 • g for 20 rain and pH of the supernatant fluid was adjusted to 4.9 (the isoelectric point of CDP) with cold 1.0 M acetic acid, allowed to stand for 20 min and then centrifuged at 14,000 x g for 20 rain. The pellet (CDP) was suspended in .1 M Tris-HCl, 1 mM EDTA, pH 7.5 and clarified by centrifugation at 148,000 x g for 60 min. Total CDP activity (micro-molar plus millimolar Ca 2+ activated forms) was assayed in the supernatant fluid using casein as substrate and monitoring released tyrosine at 278 nm as described by Dayton et al. (1976) . This procedure does not separate the micromolar and millimolar and forms of the CDP, but it does minimize the role of the CDP inhibitor.
To assay catheptic enzymes, frozen muscle was homogenized in 10 volumes of .25 M sucrose, .02 M KC1 (Moeller et al., 1977) . Homogenate pH was adjusted to 7.8 (.1 M KOH) and centrifuged at 105,000 x g for 2 h. Pellets (sedimentable fraction) were suspended in .25 M sucrose and. 1% (w/v) Triton buffer. Finally, the sedimentable fraction and 105,000 x g supernatant fluid were diluted to 1 mg protein/ml in .1% Brij-35. Protein was determined with a Biuret procedure (Gornall et al., 1949) .
Cathepsin B and H activities were determined as detailed by Barrett (1980) using ZArg-Arg-NMec [B] and Arg-NMec [HI as substrates, respectively, followed by fluoromelric determination of released 7-amino-4-methyl coumarin (NMeC) at 360 nm (excitation) and 460 nm (emission). Cathepsin L was assayed according to Kirschke et al. (1983) using Z-phe-phe-CNH2 to specifically inhibit cathepsin L. Total catheptic activity (B and L) was assayed with Z phe-arg NMec; the NMec released was determined fluorometrically (Barrett, 1980) (Gill, 1978) . Cathepsins and total CDP activities were analyzed statistically after combining results of d 14, 28 and 42 into overall means. The 21-d and 35-d FSR within the control and within the ractopamine groups were compared by oneway analysis of variance (Gill, 1978) . Within treatments (control vs ractopamine), FSR were not different at 21 and 35 d; hence, FSR data were combined into a single control vs ractopamine comparison and analyzed statistically by the t-test (Gill, 1978) . All statistical analyses were accomplished using the General Linear Models procedure (SAS, 1987 After 14 d, ST muscles tended to be heavier (not significant) for the ractopamine-fed pigs. After 28 d, ST muscles of ractopamine-fed pigs were heavier (P < .05), and after 42 d ST muscles of ractopamine-fed pigs were still heavier than those of controls (400.0 vs 367.4 g, not significant). Total ST muscle protein (g/ muscle) results mirrored the ST muscle fresh weight results; ST muscle protein concentration (g/100 g fresh wt muscle) were not affected by ractopamine at d 14 and 28, whereas by d 42 ST muscle protein concentration was greater (P < .05) in ractopamine-fed pigs. There were no differences (P > .05) in ST muscle RNA (expressed either as mg/g ST muscle or mg/total muscle) in control vs ractopamine-fed pigs at d 14, 28 and 42. Total muscle RNA increased in ST muscles over the time interval from d 14 to d 42 for both control and ractopamine treatments. DNA concentrations (mg/g ST muscle) were numerically lower in ractopamine-fed pigs at d 28 and significantly lower (P < .05) in ractopaminefed pigs at 42. However, ST muscle total DNA content did not differ for pigs fed either of the two diets at all three time points. This finding reflects a marked muscle protein hypertrophy in ractopamine-fed pigs in the absence of new DNA synthesis in ST muscles.
Protein Synthesis, Accretion and Breakdown Rates. Results from the protein synthesis, accretion and degradation study are presented in (Table 3) .
Feeding 20 ppm ractopamine to finishing barrows increased FAR by 20% in ST muscles. Ractopamine enhanced FSR (P < .06), and estimated FBR also were increased. Thus, the 20% increase in FAR was accomplished by both an increase in FSR and an apparent increase in FBR. The relative magnitude of the ractopamine effect on ST muscle protein metabolism also is depicted in Table 4 . Absolute daily protein accretion was enhanced 35%; absolute protein synthesis and breakdown increased 56% and 58%, respectively. In this study, with this beta adrenergic agonist, the sizable increase in protein accretion in ST muscle was accompanied by an increase in both synthesis and degradation.
Calcium-Dependent Proteinases and Catheptic Enzymes Activities. Proteinases (CDP and cathepsins B, H and L) were assayed in extracts of ST muscles, and the overall results are presented in Table 5 . Cathepsin L was the only protease for which a difference between 0 and 20 ppm dietary ractopamine was detected. CTotal catheptic activity; sum of sedimentable and ncmsedimentable activity. dSigniticant time of sampling effect (P < .01). no tteamumt or Tn x Time interaction effects. eunit is the release of 1 pmol of product/rain.
Discussion
It is believed widely that beta adrenergic agonist-enhanced skeletal muscle protein hypertrophy is due to decreased protein degradation coupled with marginal effects on protein synthesis. This proposition is argued strongly in reviews by Reeds (1987) and Williams (1987) . To date no study using direct measures has shown that protein breakdown declines in BAA-fed animals. Indeed, it generally is difficult to measure protein degradation rates directly (Swick and Song, 1974; Bergen et al., 1987) , and reported values for breakdown rate often are estimates based on the formula FBR = FSR -FAR (Waterlow et al., 1978) . This approach, proposed theoretically to be superior to breakdown rates estimates using NT-methylhistidine (in species in which such a measurement is valid; the NT-methylhistidine procedure cannot be used in pigs) (Waterlow et al., 1978) suffers from the fact that such data are usually single-point estimates. This problem is inherent in the experimental protocol, as can be demonstrated from our studies. Fractional protein synthesis rate values are from individual pigs, and such values can be compared statistically between treatments. The lower precision limit of the in vivo FSR assay with four pigs per treatment with available pigs from our herd is approximately .5% FSR/d. Fractional accretion rate values are based on serial slaughter, dissection and protein analysis of muscle or, as in the case of , FAR were predicted by indirect means for individual animals based on log weight/ muscle protein ratios plotted against time. Using a serial slaughter approach (as was done in this study) there will be only a single FAR value per experimental group unless a suitable number of replicate groups are utilized. In our case, four barrows were slaughtered for control and four for ractopamine treatment at d 14 and d 42, respectively. Whereas it was clear that ractopamine-fed pigs had larger ST muscles at the end of the study, the net difference between the respective FAR values was .2% fractional rate per day. The FSR assay cannot detect such small differences, yet this small increment in FAR could explain a 50% increase in muscle protein over the entire 6-wk feeding period. This value is based on an average ST muscle total protein mass of eight pigs slaughtered on d 0 (from same pool of pigs used in this study) of 51 g and ST total muscle protein of 73.2 and 84.0 g (Table 3) Others (Reeds, 1987; Williams, 1987) have reported that feeding BAA did not change FSR statistically, whereas muscle size and protein content increased. These researchers then concluded that a decreased rate of protein breakdown must be responsible for the muscle hypertrophy. We contend that because the differences in FAR between experimental groups (control vs ractopamine) are less than the variation in measurement of FSR such conclusions are unwarranted unless direct measurement of FBR can be made. We realize that this practically is impossible for pigs.
The clearest evidence that BAA depress degradation in skeletal muscle is from in vitro studies by Li and Jefferson (1977) and Garber et al. (1976) . Although such in vitro studies may be useful, these procedures suffer from the fact that muscle tissue explants usually have a negative N balance during the time course of such experiments (Bergen et al., 1987; Skjaerlund et al., 1988) . Using an intragastric infusion technique, with a N-free diet, Hovell et al. (1987) maintained sheep in positive energy balance for a period of 10 d. Clenbuterol administration for 5-d periods reduced endogenous urinary loss by 14%. HoveU et al. (1987) concluded that a decline in protein degradation accounts for this observation; it also is probable that enhanced synthesis would have lowered endogenous N loss.
The most convincing evidence that BAA depress protein degradation was presented by . Utilizing 14C-AA continuous infusion in rats, they found no differences in FSR, whereas FAR were enhanced. They concluded that FBR (not measured directly) was depressed and that clenbuterol may interfere with arachidonic acid metabolism and hence ultimately depresses the postulated PGE 2 mediated protein degradation cascade . Unfortunately, the clenbuterol-induced muscle hypertrophy (FAR) was only evident during the initial part of the feeding period. After 11 d, there were no differences in muscle FAR between control and clenbuterol-fed rats .
One observation in which all reported data involving BAA feeding agree is that RNA concentration in skeletal muscle increases or remains the same and generally parallels the increases in protein accretion (Reeds et al., , 1988 Beermann et al., 1987;  Table 3 of this study). Utilizing the concepts of Allison et al. (1963) , such findings indicate that the increased RNA provides more machinery for enhanced protein synthesis.
An increase in tissue RNA content typically is associated with increased protein synthesis (Allison ei al., 1963; Munro, 1964) . In the present study, RNA concentrations were mainrained despite the muscle hypertrophy indicating an enhanced rate of RNA synthesis (Table  3) . This also is reflected by increased RNA/ DNA ratios in pigs fed ractopamine for 28 and 42 d. The present study clearly shows an enhanced FSR of mixed skeletal muscle proteins, which we conclude can account for the skeletal muscle protein hypertrophy with ractopamine feeding. In another set of experiments, we also have demonstrated that ractopamine increased skeletal muscle alpha actin mRNA abundance in pigs (Helferich et al., 1988) , indicating a pretranslational regulation of skeletal muscle actin synthesis by ractopamine. Recently it was shown that clenbuteroI administration partially reversed the atrophy associated with denervation of skeletal muscle and restored alpha actin mRNA abundance back to control levels (Babij and Booth, 1988) .
To unequivocally establish the reason for the increased skeletal muscle protein hypertrophy, further studies are needed. Such efforts should include replicates for FAR estimates, direct assessment of FBR, more quantitative estimates of proteases and the role of their inhibitors in protein degradation, separate measures of FSR for myosin, actin, total myofibrillar proteins and sarcoplasmic proteins, and detailed studies in muscle cell tissue cultures. Finally, different BAA may have different modes of action in muscle protein metabolism (e.g., comparing ractopamine with clenbuterol, cimaterol and isoproterenol).
